Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.95
-0.08 (-1.33%)
At close: Mar 13, 2026
Sino Biopharmaceutical Employees
Sino Biopharmaceutical had 23,056 employees as of June 30, 2025. The number of employees decreased by 1,323 or -5.43% since the number was reported on December 31, 2024.
Employees
23,056
Change
-1,323
Growth
-5.43%
Revenue / Employee
1.45M HKD
Profits / Employee
183.99K HKD
Market Cap
106.37B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 23,056 | -1,323 | -5.43% |
| Dec 31, 2024 | 24,379 | -1,427 | -5.53% |
| Dec 31, 2023 | 25,806 | -466 | -1.77% |
| Dec 31, 2022 | 26,272 | 693 | 2.71% |
| Dec 31, 2021 | 25,579 | 1,471 | 6.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| WuXi Biologics | 12,552 |
| BeOne Medicines AG | 12,000 |
| 3SBio | 6,268 |
| Innovent Biologics | 6,190 |
| Shanghai Henlius Biotech | 3,537 |
| Akeso | 3,529 |
| RemeGen | 3,070 |
| Shanghai Junshi Biosciences | 2,670 |
Sino Biopharmaceutical News
- 11 days ago - Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters
- 2 years ago - Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln - Reuters
- 5 years ago - Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea - Forbes